Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38049622

First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Nat Med
Publication date
2024 Jan
First author
Fizazi K

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Med. 2024 May;30(5):1505. doi: 10.1038/s41591-024-02835-9.
    note
    Source null
    related pmid
    38297094
    relationship
    Erratum in

Authors and identifiers

  1. name
    Fizazi K
    type
    Author
  2. name
    Azad AA
    type
    Author
  3. name
    Matsubara N
    type
    Author
  4. name
    Carles J
    type
    Author
  5. name
    Fay AP
    type
    Author
  6. name
    De Giorgi U
    type
    Author
  7. name
    Joung JY
    type
    Author
  8. name
    Fong PCC
    type
    Author
  9. name
    Voog E
    type
    Author
  10. name
    Jones RJ
    type
    Author
  11. name
    Shore ND
    type
    Author
  12. name
    Dunshee C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fizazi K
    type
    Author
  2. name
    Azad AA
    type
    Author
  3. name
    Matsubara N
    type
    Author
  4. name
    Carles J
    type
    Author
  5. name
    Fay AP
    type
    Author
  6. name
    De Giorgi U
    type
    Author
  7. name
    Joung JY
    type
    Author
  8. name
    Fong PCC
    type
    Author
  9. name
    Voog E
    type
    Author
  10. name
    Jones RJ
    type
    Author
  11. name
    Shore ND
    type
    Author
  12. name
    Dunshee C
    type
    Author
bibliography ids
  1. nci-bib-4ae2931e3a13fd47410f994f
book metadata
content sha256
66f5dd040c1538e60b602fb320f9cc436e1e99d7c4e0a258c5edbc040f48f20e
document type
citation
dois
  1. 10.1038/s41591-023-02704-x
electronic publication date
display
2023 Dec 4
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:38049622
immutable id
pubmed:38049622@66f5dd040c1538e60b602fb320f9cc436e1e99d7c4e0a258c5edbc040f48f20e
journal
abbreviation
Nat Med
issn electronic
1546-170X
issn print
1078-8956
issue
1
name
Nature medicine
nlm unique id
9502015
pages
257-264
volume
30
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Med. 2024 May;30(5):1505. doi: 10.1038/s41591-024-02835-9.
    note
    Source null
    related pmid
    38297094
    relationship
    Erratum in
outcomes validated
false
pmid
38049622
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
95b03f117bb7fb31e077901370a92f2b88c8c6485268f9a05405bb3e0a401d52
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Jan
precision
month
year
2024
publication types
  1. Randomized Controlled Trial
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38049622/
title
First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.

Preserved source evidence · Not medical advice